Non-small cell lung cancer stage grouping using updated TNM 9 descriptors.
Calculated Interpretation
Stage IA
Node-negative NSCLC stage depends mainly on the T descriptor when M0.
Guidelines & Evidence
Clinical Details
Section 1
When to Use
Primary Use
Non-small cell lung cancer stage grouping using updated TNM 9 descriptors.
Section 2
Formula & Logic
Clinical Inputs
T descriptor
Categorical selection
N descriptor
Categorical selection
M descriptor
Categorical selection
Section 3
Pearls/Pitfalls
Result Bands
Section 4
Next Steps
Suggested Next Steps
01
Interpret the result in the full disease-specific clinical context.
02
Correlate with pathology, imaging, performance status, and multidisciplinary guidance.
Section 5
Evidence Appraisal
Evidence Base
Non-small cell lung cancer stage grouping using updated TNM 9 descriptors.
OpiCalc Medical Oncology Module • Lung Cancer. 2026;Logic implemented from widely used contemporary oncology classification, prognostic, and response-assessment frameworks.
Section 6
Literature
Context
TNM 9th Ed (NSCLC) is included in the oncology module as a structured decision-support tool for lung cancer workflows.
